Alana Reid counsels a broad range of healthcare and life sciences clients on regulatory, compliance, transactional, and legislative matters. Her clients include pharmaceutical and medical device manufacturers, diagnostic testing facilities, physician practice groups, clinical laboratories, and trade groups.

Specifically, Ms. Reid focuses on fraud and abuse, government pricing, and reimbursement issues, as well as regulatory-based diligence reviews and internal compliance investigations. She has experience advocating to government regulators, such as the Center for Medicare & Medicaid Services and the US Department of Health and Human Services Office of Inspector General, navigating regulatory complexities related to the launch of new product offerings and value-based arrangements, and advising on reimbursement and pricing strategies in both commercial and governmental marketplaces.

Ms. Reid received her JD from the University of Virginia School of Law, where she served as an Articles Editor of the Virginia Law Review. Also during law school, Ms. Reid was the President of the Health Law Association and participated in the Child Advocacy Clinic. Prior to law school, Ms. Reid worked as a functionality and policy consultant for an information technology firm implementing the state-based Health Insurance Exchanges in use in two states. She received her Bachelors of Science from Cornell University in Industrial and Labor Relations.


Medicare and FCC Take Additional Steps to Support the Frontline Battling COVID-19
Coronavirus: Life Sciences and Healthcare Regulatory Advisory
Telehealth During COVID-19: New Rules And Considerations
Commercial Contracts Law360, Compliance Law360, Consumer Protection Law360, Cybersecurity & Privacy Law360, Health Law360, Life Sciences Law360, Personal Injury & Medical Malpractice Law360, Public Policy Law360, Technology Law360, Telecommunications Law360
Expanding Telehealth Services to Fight COVID-19
Coronavirus: Life Sciences and Healthcare Regulatory Advisory
Questions & Answers Guide to FDA’s Prescription Drug Importation Proposals
HHS Proposes New Protections for Value-Based Arrangements and Other Revisions to AKS Safe Harbors, CMP Exceptions and Stark Exceptions


  • JD, University of Virginia School of Law, 2018
  • BS, Industrial and Labor Relations, Cornell University, 2012
  • District of Columbia
  • Texas

Email Disclaimer